Reduced Plasma Nisoldipine Concentrations in Phenytoin‐Treated Patients with Epilepsy

Abstract

These results suggest that phenytoin increases the first-pass metabolism of nisoldipine to a clinically important extent. In view of the magnitude and variability of interaction, use of nisoldipine in patients receiving chronic phenytoin therapy is contraindicated.